Us Bancorp \De\ Sangamo Therapeutics, Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 23 shares of SGMO stock, worth $26. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 23 -0.0%

Holding current value

$26

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$0.32 - $1.1 $163 - $563	-512 Reduced 95.7%	23 $0
Q2 2024 Aug 06, 2024	BUY	$0.36 - $0.65 $192 - $347	535 New	535 $0
Q2 2023 Aug 09, 2023	SELL	$1.11 - $1.74 $6,785 - $10,636	-6,113 Reduced 55.01%	5,000 $6,000
Q1 2023 May 09, 2023	BUY	$1.66 - $3.67 $8,636 - $19,095	5,203 Added 88.04%	11,113 $19,000
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $6,575 - $12,036	-2,374 Reduced 28.66%	5,910 $18,000
Q3 2022 Oct 27, 2022	SELL	$4.27 - $6.39 $789 - $1,182	-185 Reduced 2.18%	8,284 $41,000
Q2 2022 Aug 01, 2022	BUY	$3.28 - $6.21 $1,075 - $2,036	328 Added 4.03%	8,469 $35,000
Q1 2022 May 11, 2022	BUY	$5.23 - $7.82 $7,750 - $11,589	1,482 Added 22.26%	8,141 $47,000
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $7,464 - $11,233	1,024 Added 18.17%	6,659 $50,000
Q3 2021 Nov 10, 2021	SELL	$9.01 - $12.01 $495 - $660	-55 Reduced 0.97%	5,635 $51,000
Q2 2021 Aug 05, 2021	BUY	$10.17 - $12.64 $7,017 - $8,721	690 Added 13.8%	5,690 $68,000
Q1 2020 May 13, 2020	SELL	$5.05 - $8.85 $888 - $1,557	-176 Reduced 3.4%	5,000 $32,000
Q2 2019 Aug 13, 2019	SELL	$8.75 - $13.03 $1,172 - $1,746	-134 Reduced 2.52%	5,176 $56,000
Q2 2018 Aug 08, 2018	SELL	$13.9 - $19.8 $3,600 - $5,128	-259 Reduced 4.65%	5,310 $75,000
Q1 2018 May 08, 2018	BUY	$16.7 - $26.35 $9,502 - $14,993	569 Added 11.38%	5,569 $106,000
Q4 2017 Feb 02, 2018	SELL	$11.6 - $17.35 $8,700 - $13,012	-750 Reduced 13.04%	5,000 $82,000
Q3 2017 Nov 13, 2017	BUY	$8.4 - $15.0 $48,300 - $86,250	5,750	5,750 $86,000

Others Institutions Holding SGMO

# of Institutions

134

Shares Held

52.5M

Call Options Held

1.02M

Put Options Held

1.61M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account